QUILT-3.080: NANT Pancreatic Cancer Vaccine

NCT03586869 PHASE1, PHASE2 TERMINATED Results posted

This is a phase 1b/2 study to evaluate the safety and efficacy of metronomic combination therapy in subjects with pancreatic cancer who have progressed on or after previous Standard of Care (SoC) chemotherapy.

Details

Lead sponsor	ImmunityBio, Inc.
Phase	PHASE1, PHASE2
Status	TERMINATED
Enrolment	3
Start date	Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Aug 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Pancreatic Cancer

Interventions

• Aldoxorubicin HCl
• ALT-803
• ETBX-011
• ETBX-021
• ETBX-051
• ETBX-061
• GI-4000
• GI-6207
• GI-6301
• haNK for infusion

Countries

United States